Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer


Dogan A., Demirci S., Telci D., CANIKYAN S., KONGUR M., DEDE B., ...More

INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.50, no.2, pp.247-255, 2018 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 50 Issue: 2
  • Publication Date: 2018
  • Doi Number: 10.1007/s11255-017-1782-9
  • Journal Name: INTERNATIONAL UROLOGY AND NEPHROLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.247-255

Abstract

Renal cell carcinoma (RCC) accounts for approximately 80% of the primary renal cancers, and current treatment strategies are not sufficient to provide a certain solution. Since there are not many treatment options, interest in discovery of alternative drugs has increased.